MRC1 and triple-negative breast carcinoma: We previously reported that GRP94 inhibition in a triple-negative breast cancer (TNBC) murine model induced a decrease in intra-tumoral CD206 + M2-like macrophages that correlated with a decrease in collagen content, an increase in CD8+ cells in tumors and a reduced tumor volume.